Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04729621 · ClinicalTrials.gov registry record · Phase 3
A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis
A Phase 3 study, sponsored by Teva Pharmaceuticals USA.
- Completed
- Registry status
- Phase 3
- Development phase
- 332
- Enrollment target
NCT04729621: Completed Phase 3 study, sponsored by Teva Pharmaceuticals USA.
NCT04729621 is a Phase 3 study that has completed, run by Teva Pharmaceuticals USA. The registered enrollment target is 332 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04729621, a Phase 3 study, has completed, sponsored by Teva Pharmaceuticals USA.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 332 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate similar efficacy and safety between TVB-009 and Prolia® (denosumab)
Primary Outcome
Percent change from baseline in lumbar spine bone mineral density (LS BMD) based on centrally assessed dual energy X ray absorptiometry (DXA) at week 52
Interventions
- COMBINATION_PRODUCT TVB-009
- COMBINATION_PRODUCT Prolia®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 332 participants |
| Start Date | 2021-03-22 |
| Est. Completion | 2023-06-19 |
| Phase | Phase 3 |
What the finished NCT04729621 record still lists
NCT04729621 is an interventional study that assigns participants to a tested intervention. The registered 332 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 2 interventions - of which TVB-009 is the first listed.
NCT04729621 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04729621 about?
NCT04729621 is a clinical study titled "A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis". The purpose of this study is to demonstrate similar efficacy and safety between TVB-009 and Prolia® (denosumab)
What is the current status of trial NCT04729621?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 332 participants. The study started on 2021-03-22. Estimated completion is 2023-06-19.
What interventions are being tested in trial NCT04729621?
The interventions under investigation include: TVB-009 (COMBINATION_PRODUCT), Prolia® (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04729621?
This trial is sponsored by Teva Pharmaceuticals USA, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04729621's enrollment target sits among peer trials
332 1061st of 2000 higher than 935 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174121 · 332 participants · Phase 2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- NCT02605785 · 332 participants · NA
A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
- NCT04894006 · 332 participants · NA
Dementia Family Caregiver Study
- NCT05130606 · 332 participants · NA
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI